High-Grade prostatic intraepithelial neoplasia

Korean Journal of Urology

Volumn 53, Issue 5, 2012, Pages 297-303

  Klink, Joseph C ^a   Miocinovic, Ranko ^a   Galluzzi, Cristina Magi ^a   Klein, Eric A ^a  

^a Glickman Urologic and Kidney Institute   (United States)

Author keywords

HGPIN; High grade prostatic intraepithelial neoplasia; Prostate biopsy; Prostate cancer

Indexed keywords

DUTASTERIDE; FINASTERIDE; PROSTATE SPECIFIC ANTIGEN; TELOMERASE;

CANCER GROWTH; GENE MUTATION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; PREDICTIVE VALUE; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW;

EID: 84861899898     PISSN: 20056737     EISSN: 20056745     Source Type: Journal    
DOI: 10.4111/kju.2012.53.5.297     Document Type: Review

References (68)

1. Epstein JI, Grignon DJ, Humphrey PA, McNeal JE, Sesterhenn IA, Troncoso P, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995;19:873-86.
2. McNeal JE, Bostwick DG. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 1986;17:64-71.
3. Allam CK, Bostwick DG, Hayes JA, Upton MP, Wade GG, Domanowski GF, et al. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocar-cinoma. Mod Pathol 1996;9:742-51.
4. Bostwick DG, Cheng L. Precursors of prostate cancer. Histopath-ology 2012;60:4-27.
5. Guzzo TJ, Kutikov A, Canter DJ, Tomaszewski JE, Magerfleish L, VanArsdalen K, et al. The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Can J Urol 2008;15: 4174-8.
6. Lefkowitz GK, Taneja SS, Brown J, Melamed J, Lepor H. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J Urol 2002;168:1415-8.
7. Antonelli A, Tardanico R, Giovanessi L, Pesenti N, Gatti L, Zambolin T, et al. Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. Prostate Cancer Prostatic Dis 2011;14:173-6.
8. Bostwick DG. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996;78:330-6.
9. Häggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol 1997;158:12-22.
10. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 2007;4:321-32.
11. Abdel-Khalek M, El-Baz M, Ibrahiem el-H. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model. BJU Int 2004;94:528-33.
12. Roscigno M, Scattoni V, Freschi M, Raber M, Colombo R, Bertini R, et al. Monofocal and plurifocal high-grade prostatic intra-epithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology 2004;63:1105-10.
13. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neo-plasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Pathol 2001;25:1079-85.
14. Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jerónimo C, et al. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions. Neoplasia 2006;8:826-32.
15. Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007;31:882-8.
16. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intra-epithelial neoplasia. Eur Urol 1996;30:138-44.
17. Sakr WA, Grignon DJ, Haas GP. Pathology of premalignant lesions and carcinoma of the prostate in African-American men. Semin Urol Oncol 1998;16:214-20.
18. Epstein JI, Herawi M. Prostate needle biopsies containing pro-static intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006;175:820-34.
19. Zynger DL, Yang X. High-grade prostatic intraepithelial neo-plasia of the prostate: the precursor lesion of prostate cancer. Int J Clin Exp Pathol 2009;2:327-38.
20. Han KS, Jeong IG, Joung JY, Yang SO, Chung J, Seo HK, et al. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy. Urology 2007;70:1100-3.
21. Tan PH, Tan HW, Tan Y, Lim CN, Cheng C, Epstein JI, et al. Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: a clinicopathologic study performed in Singapore. Urology 2006;68:800-3.
22. Weinstein MH, Epstein JI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol 1993;24: 624-9.
23. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol 1995;154:347-51.
24. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001;165:1409-14.
25. Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004;17:360-79.
26. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, et al. Allelic loss on chromosome 8p12-21 in mi-crodissected prostatic intraepithelial neoplasia. Cancer Res 1995;55:2959-62.
27. Miet SM, Neyra M, Jaques R, Dubernard P, Revol AA, Marçais C. RER(+) phenotype in prostate intra-epithelial neoplasia associated with human prostate-carcinoma development. Int J Cancer 1999;82:635-9.
28. Baltaci S, Orhan D, Ozer G, Tolunay O, Gögõüs O. Bcl-2 pro-to-oncogene expression in low- and high-grade prostatic intra-epithelial neoplasia. BJU Int 2000;85:155-9.
29. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-14.
30. Willman JH, Holden JA. Immunohistochemical staining for DNA topoisomerase II-alpha in benign, premalignant, and malignant lesions of the prostate. Prostate 2000;42:280-6.
31. Ge K, Minhas F, Duhadaway J, Mao NC, Wilson D, Buccafusca R, et al. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma. Int J Cancer 2000;86:155-61.
32. Koeneman KS, Pan CX, Jin JK, Pyle JM 3rd, Flanigan RC, Shankey TV, et al. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN). J Urol 1998;160:1533-9.
33. Mosquera JM, Perner S, Genega EM, Sanda M, Hofer MD, Mertz KD, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res 2008;14:3380-5.
34. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-34.
35. Montironi R, Mazzucchelli R, Lopez-Beltran A, Scarpelli M, Cheng L. Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance. BJU Int 2011;108:1394-401.
36. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
37. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008;27:253-63.
38. Perner S, Demichelis F, Beroukhim R, Schmidt FH, Mosquera JM, Setlur S, et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 2006;66:8337-41.
39. Gopalan A, Leversha MA, Satagopan JM, Zhou Q, Al-Ahmadie HA, Fine SW, et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res 2009;69:1400-6.
40. Morote J, Fernández S, Alaña L, Iglesias C, Planas J, Reventós J, et al. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin Cancer Res 2008;14:2617-22.
41. Evren S, Dermen A, Lockwood G, Fleshner N, Sweet J. mTOR-RAPTOR and 14-3-3sigma immunohistochemical expression in high grade prostatic intraepithelial neoplasia and pro-static adenocarcinomas: a tissue microarray study. J Clin Pathol 2011;64:683-8.
42. Swinnen JV, Roskams T, Joniau S, Van Poppel H, Oyen R, Baert L, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 2002;98:19-22.
43. Yasunaga Y, Shin M, Fujita MQ, Nonomura N, Miki T, Okuyama A, et al. Different patterns of p53 mutations in prostatic intra-epithelial neoplasia and concurrent carcinoma: analysis of micro-dissected specimens. Lab Invest 1998;78:1275-9.
44. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;7:531-6.
45. Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 1987;59:788-94.
46. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol 1993;24:298-310.
47. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol 2005;29:1201-7.
48. Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology 2012;60:4-27.
49. Herawi M, Kahane H, Cavallo C, Epstein JI. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. J Urol 2006;175:121-4.
50. Eskicorapci SY, Guliyev F, Islamoglu E, Ergen A, Ozen H. The effect of prior biopsy scheme on prostate cancer detection for repeat biopsy population: results of the 14-core prostate biopsy technique. Int Urol Nephrol 2007;39:189-95.
51. Lee MC, Moussa AS, Zaytoun O, Yu C, Jones JS. Using a saturation biopsy scheme increases cancer detection during repeat biopsy in men with high-grade prostatic intra-epithelial neoplasia. Urology 2011;78:1115-9.
52. Rabets JC, Jones JS, Patel A, Zippe CD. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 2004;172:94-7.
53. Roscigno M, Scattoni V, Freschi M, Abdollah F, Maccagnano C, Galosi A, et al. Diagnosis of isolated high-grade prostatic in-tra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy. BJU Int 2011;Epub ahead of print
54. Akhavan A, Keith JD, Bastacky SI, Cai C, Wang Y, Nelson JB. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. BJU Int 2007;99:765-9.
55. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71.
56. Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw 2010;8:240-62.
57. Gallo F, Chiono L, Gastaldi E, Venturino E, Giberti C. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. Urology 2008;72:628-32.
58. Thompson IM, Lucia MS, Redman MW, Darke A, La Rosa FG, Parnes HL, et al. Finasteride decreases the risk of prostatic intra-epithelial neoplasia. J Urol 2007;178:107-9.
59. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192-202.
60. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006;66:1234-40.
61. Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, et al. Progression from high-grade prostatic intraepithelial ne-oplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol 2011;29:2386-90.
62. Lefkowitz GK, Sidhu GS, Torre P, Lepor H, Taneja SS. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001;58: 999-1003.
63. Moore CK, Karikehalli S, Nazeer T, Fisher HA, Kaufman RP Jr, Mian BM. Prognostic significance of high grade prostatic intra-epithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173:70-2.
64. Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, et al. The incidence of high-grade prostatic intraepithelial neo-plasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007;99:770-4.
65. De Nunzio C, Trucchi A, Miano R, Stoppacciaro A, Fattahi H, Cicione A, et al. The number of cores positive for high grade pro-static intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy. J Urol 2009;181:1069-74.
66. Antonelli A, Tardanico R, Giovanessi L, Pesenti N, Gatti L, Zambolin T, et al. Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. Prostate Cancer Prostatic Dis 2011;14: 173-6.
67. Bishara T, Ramnani DM, Epstein JI. High-grade prostatic intra-epithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern. Am J Surg Pathol 2004;28:629-33.
68. Netto GJ, Epstein JI. Widespread high-grade prostatic intra-epithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 2006;30:1184-8.